CIK 0001253689 · Non-accelerated filer<br>Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- 4 Grant or award Director acquired 6,667 shares (grant or award)
- 4 Open-market buy Chief Medical Officer bought 65,403 shares at $1.38 ($90,256)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Option exercise Director acquired 21,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 4 Open-market sale SVP Finance, CFO sold 3,700 shares at $1.95 ($7,215)
- 144 Insider Sale of Securities
- 4 Open-market buy Director bought 30,000 shares at $1.56 ($46,800)
- 4 Open-market buy SVP & Chief Commercial Officer bought 13,500 shares at $1.57 ($21,195)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Material agreement
Page 12 of 34 · 678 filings